Baogong Zhu

10.1k total citations · 3 hit papers
15 papers, 5.5k citations indexed

About

Baogong Zhu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Baogong Zhu has authored 15 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Baogong Zhu's work include Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Baogong Zhu is often cited by papers focused on Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Baogong Zhu collaborates with scholars based in United States, Spain and Italy. Baogong Zhu's co-authors include Gordon J. Freeman, Arlene H. Sharpe, Rafi Ahmed, Daniel L. Barber, E. John Wherry, David Masopust, James P. Allison, Guifang Cai, Dale T. Umetsu and Rosemarie H. DeKruyff and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Baogong Zhu

15 papers receiving 5.4k citations

Hit Papers

Restoring function in exhausted CD8 T cells during chroni... 2005 2026 2012 2019 2005 2008 2007 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baogong Zhu United States 12 4.0k 2.2k 873 763 489 15 5.5k
Haina Shin United States 19 3.5k 0.9× 1.6k 0.7× 847 1.0× 432 0.6× 314 0.6× 28 4.5k
Joël Plumas France 37 3.7k 0.9× 1.1k 0.5× 634 0.7× 1.2k 1.5× 258 0.5× 104 5.4k
Nasim Kassam United States 20 5.3k 1.3× 2.6k 1.2× 523 0.6× 847 1.1× 946 1.9× 24 7.0k
Georg Gasteiger Germany 33 3.9k 1.0× 889 0.4× 642 0.7× 778 1.0× 200 0.4× 63 5.2k
Danielle Lenig Switzerland 8 6.5k 1.6× 2.1k 0.9× 862 1.0× 868 1.1× 584 1.2× 8 7.7k
Sophie Caillat‐Zucman France 50 4.1k 1.0× 1.3k 0.6× 1.4k 1.6× 1.3k 1.7× 513 1.0× 191 7.8k
Sang‐Jun Ha South Korea 45 6.3k 1.6× 3.8k 1.7× 1.3k 1.5× 2.1k 2.8× 541 1.1× 141 9.6k
Julia A. Brown United States 21 4.1k 1.0× 1.6k 0.7× 702 0.8× 573 0.8× 151 0.3× 37 6.2k
Marcel Loetscher Switzerland 19 5.5k 1.4× 4.3k 2.0× 605 0.7× 1.1k 1.4× 1.1k 2.2× 22 7.7k
S. Cindy Australia 38 6.1k 1.5× 1.2k 0.5× 689 0.8× 735 1.0× 221 0.5× 89 7.4k

Countries citing papers authored by Baogong Zhu

Since Specialization
Citations

This map shows the geographic impact of Baogong Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baogong Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baogong Zhu more than expected).

Fields of papers citing papers by Baogong Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baogong Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baogong Zhu. The network helps show where Baogong Zhu may publish in the future.

Co-authorship network of co-authors of Baogong Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Baogong Zhu. A scholar is included among the top collaborators of Baogong Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baogong Zhu. Baogong Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bu, Xia, Vikram R. Juneja, Carol Reynolds, et al.. (2021). Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses. Cancer Immunology Research. 9(12). 1465–1475. 11 indexed citations
2.
Bhatt, Rupal S., Kathleen M. Mahoney, Samuel S. Freeman, et al.. (2020). KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Cancer Immunology Research. 9(2). 156–169. 80 indexed citations
3.
Chaudhri, Apoorvi, et al.. (2018). PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface. Cancer Immunology Research. 6(8). 921–929. 136 indexed citations
4.
Mahoney, Kathleen M., Sachet A. Shukla, Nikolaos Patsoukis, et al.. (2018). A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression. Cancer Immunology Immunotherapy. 68(3). 421–432. 112 indexed citations
5.
Chaudhri, Apoorvi, Yanping Xiao, Baogong Zhu, & Gordon J. Freeman. (2017). PD-L1 binds with B7-1 only in cis on the same cell surface. The Journal of Immunology. 198(Supplement_1). 154.11–154.11. 2 indexed citations
6.
Xiao, Yanping, Sanhong Yu, Baogong Zhu, et al.. (2014). RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. The Journal of Experimental Medicine. 211(5). 943–959. 256 indexed citations
7.
Fuller, Michael J., Benoît Callendret, Baogong Zhu, et al.. (2013). Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proceedings of the National Academy of Sciences. 110(37). 15001–15006. 140 indexed citations
8.
D’Addio, Francesca, Takuya Ueno, Michael Clarkson, et al.. (2013). CD160Ig Fusion Protein Targets a Novel Costimulatory Pathway and Prolongs Allograft Survival. PLoS ONE. 8(4). e60391–e60391. 19 indexed citations
9.
Hainz, Ursula, Ute Burkhardt, Kristen E. Stevenson, et al.. (2012). CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells. Cancer Immunology Immunotherapy. 62(2). 347–357. 26 indexed citations
10.
Zhu, Baogong, et al.. (2010). TIM-4 mediated phagocytosis of apoptotic cells induces regulatory cytokine secretion by mouse peritoneal macrophages (136.47). The Journal of Immunology. 184(Supplement_1). 136.47–136.47. 1 indexed citations
11.
Cai, Guifang, Anukanth Anumanthan, Julia A. Brown, et al.. (2008). CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nature Immunology. 9(2). 176–185. 267 indexed citations
12.
Velu, Vijayakumar, Kehmia Titanji, Baogong Zhu, et al.. (2008). Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 458(7235). 206–210. 604 indexed citations breakdown →
13.
Zhu, Baogong, et al.. (2007). In-Fusion™ Assembly: Seamless Engineering of Multidomain Fusion Proteins, Modular Vectors, and Mutations. BioTechniques. 43(3). 354–359. 211 indexed citations
14.
Kobayashi, Norimoto, Piia Karisola, Victor Peña‐Cruz, et al.. (2007). TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells. Immunity. 27(6). 927–940. 523 indexed citations breakdown →
15.
Barber, Daniel L., E. John Wherry, David Masopust, et al.. (2005). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439(7077). 682–687. 3111 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026